Prognostic and predictive factors for breast cancer: Translating technology to oncology

被引:21
作者
Hayes, DF [1 ]
机构
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
关键词
D O I
10.1200/JCO.2005.10.074
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1596 / 1597
页数:2
相关论文
共 8 条
  • [1] Abe O, 1998, LANCET, V352, P930
  • [2] Circulating and disseminated tumor cells
    Braun, S
    Naume, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1623 - 1626
  • [3] Clarke M, 1998, LANCET, V351, P1451
  • [4] UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years
    Peto, R
    Boreham, J
    Clarke, M
    Davies, C
    Beral, V
    [J]. LANCET, 2000, 355 (9217) : 1822 - 1822
  • [5] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
    Slamon, DJ
    Leyland-Jones, B
    Shak, S
    Fuchs, H
    Paton, V
    Bajamonde, A
    Fleming, T
    Eiermann, W
    Wolter, J
    Pegram, M
    Baselga, J
    Norton, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) : 783 - 792
  • [6] Gene expression profiling of breast cancer: A new tumor marker
    van't Veer, LJ
    Paik, S
    Hayes, DF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1631 - 1635
  • [7] Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719
  • [8] Physician/patient decision aids for adjuvant therapy
    Whelan, TJ
    Loprinzi, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1627 - 1630